1,2-dipalmitoylphosphatidylcholine has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, HM; Darwitan, A; Muktabar, A; Ng, KW; Nguyen, LTH; Rakshit, M; Tang, J; Venkatraman, S | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Atherogenesis
| Article | Year |
|---|---|
Liposome interaction with macrophages and foam cells for atherosclerosis treatment: effects of size, surface charge and lipid composition.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Atherosclerosis; Cell Line; Cell Survival; Cholesterol; Endocytosis; Foam Cells; Humans; Liposomes; Macrophages; Particle Size; Phagocytosis; Surface Properties | 2021 |